Literature DB >> 10657650

Role of tumor cell apoptosis in tumor antigen migration to the draining lymph nodes.

B Bonnotte1, N Favre, M Moutet, A Fromentin, E Solary, M Martin, F Martin.   

Abstract

Establishment of an immune response against cancer may depend on the capacity of dendritic cells to transfer tumor Ags into T cell-rich areas. To check this possibility, we used a colon cancer cell variant that yields tumors undergoing complete T cell-dependent rejection when injected into syngeneic rats. We previously demonstrated that immunogenicity of these tumors depended on the early apoptosis of a part of these tumor cells. In this paper we show that fluorescent tumor cell proteins are released from FITC-labeled tumor cells and undergo engulfment by tumor-infiltrating monocytes without a phenotype of mature dendritic cells or macrophages. Fluorescence-labeled mononuclear cells with a phenotype of MHC class II+ dendritic cells are also found in the T cell areas of the draining lymph nodes. Interestingly, no fluorescent cell can be found in lymph nodes after a s.c. injection of Bcl2-transfected apoptosis-resistant tumor cells that yielded progressive tumors. Proliferation of tumor-immune T lymphocytes was induced by dendritic cells isolated from the draining lymph nodes recovered after a s.c. injection of apoptosis-sensitive, but not apoptosis-resistant, tumor cells. These results show that tumor cell apoptosis releases proteins that are engulfed by inflammatory cells in the tumor, then transported to lymph node T cell areas where they can induce a specific immune response leading to tumor rejection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10657650     DOI: 10.4049/jimmunol.164.4.1995

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

1.  Tumours can act as adjuvants for humoral immunity.

Authors:  D M Brown; T L Fisher; C Wei; J G Frelinger; E M Lord
Journal:  Immunology       Date:  2001-04       Impact factor: 7.397

2.  Angiogenesis and dendritic cell density are not correlated with metachronous distant metastasis in curatively operated rectal cancer.

Authors:  K Günther; T Radkow; M A Reymond; R Pflüger; A Dimmler; W Hohenberger; T Papadopoulos
Journal:  Int J Colorectal Dis       Date:  2003-02-08       Impact factor: 2.571

3.  Increased serum transforming growth factor-beta1 in human colorectal cancer correlates with reduced circulating dendritic cells and increased colonic Langerhans cell infiltration.

Authors:  A Huang; J W Gilmour; N Imami; P Amjadi; D C Henderson; T G Allen-Mersh
Journal:  Clin Exp Immunol       Date:  2003-11       Impact factor: 4.330

4.  Biomarker selection for detection of occult tumour cells in lymph nodes of colorectal cancer patients using real-time quantitative RT-PCR.

Authors:  L Ohlsson; M-L Hammarström; A Israelsson; L Näslund; A Oberg; G Lindmark; S Hammarström
Journal:  Br J Cancer       Date:  2006-06-06       Impact factor: 7.640

Review 5.  Leveraging Endogenous Dendritic Cells to Enhance the Therapeutic Efficacy of Adoptive T-Cell Therapy and Checkpoint Blockade.

Authors:  Mie Linder Hübbe; Ditte Elisabeth Jæhger; Thomas Lars Andresen; Mads Hald Andersen
Journal:  Front Immunol       Date:  2020-09-25       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.